Figures & data
Figure 1. Some decision points and patient considerations in the commissioning and use of biologics for IMID treatment in England.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research